Abstract
Refugee camp populations are expected to be vulnerable to COVID-19 due to overcrowding, unsanitary conditions, and inadequate medical facilities. Because there has been no COVID-19 outbreak in a refugee camp to date, the potential for nonpharmaceutical interventions to slow the spread of COVID-19 in refugee camps remains untested. We used an agent-based model to simulate COVID-19 outbreaks in the Moria refugee camp, and we studied the effects of feasible interventions. Subdividing the camp (‘sectoring’) “flattened the curve,” reducing peak infection by up to 70% and delaying peak infection by up to several months. The use of face masks coupled with efficient isolation of infected individuals reduced the overall incidence of infection and sometimes averted epidemics altogether. These interventions must be implemented quickly to be effective. Lockdowns had little effect on COVID-19 dynamics. Our findings provide an evidence base for camp managers planning intervention strategies against COVID-19 or future epidemics.
Competing Interest Statement
RTG reports grants from the European Union's Horizon 2020 research and innovation programme outside of the submitted work. ATC reports grants from NERC and AHRC outside the submitted work. SM-S is the director and CH is a board member (both without financial interest) of the NGO Kitrinos Healthcare (a UK registered charity providing free healthcare inside the Moria camp).
Funding Statement
This study was not externally funded. RTG was partially supported by Engineering and Physical Sciences Research Council grant number EP/M506436 during the course of this study, but the funder took no active role in the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Manchester Office of Research Governance, Ethics and Integrity
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Original codes for models presented in this study are currently available from the corresponding author. Upon publication of the study, codes and data will be made freely available through the Open Science Foundation (https://osf.io/).
